Gonadorelin is synthetic gonadotropin-releasing hormone (GnRH), the hypothalamic peptide that tells the pituitary to release LH and FSH. It has been used clinically for diagnostic testing, hypogonadotropic hypogonadism, and pulsatile fertility induction. In recent years it has become popular as a replacement for HCG in some TRT protocols to maintain testicular size and function.
The pharmacology here is unusual: how you dose it matters as much as how much you dose.
What it does
- Binds GnRH receptors on pituitary gonadotrophs
- Triggers LH and FSH release
- Half-life is short (2-10 minutes)
- Pulsatile dosing mimics natural rhythm; continuous dosing causes receptor downregulation (the basis of GnRH agonist therapy in prostate cancer)
This is why frequent micro-doses behave very differently from larger spaced doses.
Typical protocol shape
Trial standards for pulsatile fertility use a pump delivering 5-20 mcg every 90-120 minutes. Self-experimenters on TRT cannot replicate that and instead commonly report:
- 100-300 mcg subcutaneous, 2-3x per day, or
- 200-500 mcg subcutaneous, 2-3x per week on a TRT cruise
The realistic goal of the lower-frequency protocol is preserving testicular volume and intratesticular testosterone, not perfectly mimicking endogenous pulses.
What to track daily
- Dose, time, injection site
- Testicular size by feel (subjective but useful)
- Morning erection quality (0-10)
- Libido (0-10)
- Mood and energy
- Any injection-site reaction (mast cell activation reported by some users)
What to track weekly
- Testicular volume by orchidometer or caliper if you have one
- Photos for size tracking (private notes)
- Sleep averages
- Exercise performance
Peptide IA handles this well with private custom fields you can keep out of any export.
Bloodwork worth doing
Timing is critical because gonadorelin's effect is short-lived.
- Baseline: total and free T, LH, FSH, estradiol (sensitive assay), SHBG, prolactin
- 6-8 weeks in: same panel
- LH and FSH are most informative drawn 30-60 minutes post-injection
- Semen analysis if fertility is a goal
Realistic expectations
- Testicular volume preservation is the most realistic outcome on TRT
- Fertility restoration is plausible but not guaranteed; HCG and FSH have stronger evidence
- Subjective "feel" improvements vary widely
- Receptor desensitization is a real concern with too-frequent or too-high dosing
Common mistakes
- Treating gonadorelin like HCG (HCG mimics LH directly; gonadorelin asks the pituitary to do it)
- Dosing so frequently that you risk downregulation
- Not adjusting bloodwork timing for the short half-life
- Assuming it will restart a fully shut-down axis on its own
A tracking template
- Daily: doses, timing, libido, AM erection, mood
- Weekly: testicular size, performance, sleep
- 6-8 weekly: full hormone panel
- Before/after: semen analysis if relevant
Safety notes
Gonadorelin is generally well tolerated. The main practical concerns are hypersensitivity reactions at the injection site and the receptor-desensitization issue with poor dosing strategy.
Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.